Skip to content

Read More

The art of the possible: Charlie Hurt on the Trump-Musk cosmic bromance

Advertisement

FILE- In this Monday, March 1, 2021, file photo, a health worker displays a COVISHIELD vaccine before administering it to an elderly person in Gauhati, India. Experts say there is a pressing need for India to bolster vaccination, which started sluggishly in January. The country is expanding its drive to include everyone over 45 from Thursday, April 1. Spotlight on Serum Institute of India - the world’s largest maker of vaccines and key global supplier - to cater to cases at home has resulted in delays of global shipments of up to 90 million doses under the U.N.-backed COVAX program, an initiative devised to give countries access to vaccines regardless of their wealth. (AP Photo/Anupam Nath, file)

FILE- In this Monday, March 1, 2021, file photo, a health worker displays a COVISHIELD vaccine before administering it to an elderly person in Gauhati, India. Experts say there is a pressing need for India to bolster vaccination, which started sluggishly in January. The country is expanding its drive to include everyone over 45 from Thursday, April 1. Spotlight on Serum Institute of India - the world’s largest maker of vaccines and key global supplier - to cater to cases at home has resulted in delays of global shipments of up to 90 million doses under the U.N.-backed COVAX program, an initiative devised to give countries access to vaccines regardless of their wealth. (AP Photo/Anupam Nath, file)

Featured Photo Galleries